Corline Biomedical AB Cash Flow Reinvestment Rate
Corline Biomedical AB cash flow reinvestment rate. Corline Biomedical AB (CLBIO) has a Cash Flow Reinvestment Rate of 0.16x as of June 2026, reinvesting Skr19.00K (capex Skr19.00K ) from operating cash flow of Skr122.00K. See Corline Biomedical AB leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Corline Biomedical AB (2023–2023)
Cash flow reinvestment rate of Corline Biomedical AB from 2023 to 2023. Historical reinvestment intensity for Corline Biomedical AB across 1 annual periods. Explore how well can Corline Biomedical AB service its debt to assess how comfortably operating cash covers total debt obligations.
Corline Biomedical AB Cash Flow Reinvestment Rate by Year (2023–2023)
Corline Biomedical AB cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for Corline Biomedical AB. For the full cash flow conversion analysis, see Corline Biomedical AB cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 23.23x | Skr20.59 Million | Skr886.00K | Skr10.62 Million | — |